Can egg yolk powder fight brain cancer? small trial begins

NCT ID NCT07364786

Recruiting now Disease control Sponsor: Peter Siesjö Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early trial tests whether a dietary supplement called Salovum (made from egg yolk) can reduce pressure inside glioblastoma brain tumors. Ten adults with suspected glioblastoma will take Salovum for two days after a biopsy. Researchers will measure tumor pressure and inflammation before and during treatment. This is a very small, early study focused on safety and biological effects, not a cure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Salovum (egg yolk powder enriched with antisecretory factor)
What this could lead to: If it works, this could point toward a way to reduce tumor pressure and inflammation in glioblastoma, possibly improving outcomes.
What could go wrong: This is a very small early-phase trial with only 10 people. It is designed to measure short-term effects, not to prove the treatment works. There is no guarantee it will lead to a real treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOBLASTOMA

Contacts and locations

Locations

Department of Neurosurgery, Skane University Hospital
RECRUITING

Lund, 221 85, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.